【券商聚焦】招银国际料医药行业的盈利有望从下半年开始逐步修复

金吾财讯
23 Sep 2024

金吾财讯 | 招银国际表示,年初至今,MSCI中国医疗指数下跌23.0%,跑输MSCI中国指数25.4%。目前行业指数的动态市盈率为25.4倍,低于12年历史均值。9月19日,美联储宣布降息50个基点,正式开启降息周期。该行认为,海外降息或将推动高弹性的创新药/器械板块以及CXO板块估值反弹。国内新一轮医保谈判即将落地,尽管医保资金收支存在一定压力,该行认为医保资金支持创新药的政策趋势不会改变。医疗反腐进入常态化,医药行业的盈利有望从2H24开始逐步修复。看好龙头CXO、龙头创新药、业绩扎实且估值吸引的消费医疗企业。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10